Literature DB >> 21712856

Serpentine fibula polycystic kidney syndrome is part of the phenotypic spectrum of Hajdu-Cheney syndrome.

Mary J Gray1, Chong Ae Kim, Debora Romeo Bertola, Paula Ricci Arantes, Helen Stewart, Michael A Simpson, Melita D Irving, Stephen P Robertson.   

Abstract

Serpentine fibula polycystic kidney syndrome (SFPKS; MIM600330) is a rare skeletal dysplasia that has polycystic kidneys and dysmorphic facies as additional defining phenotypic components. The nosological classification of this disease has been debated as the condition shares features common to other skeletal dysplasias such as Melnick Needles syndrome (MNS; MIM309350) and Hajdu-Cheney Syndrome (HCS; MIM102500). Here, two previously reported cases of SFPKS are presented with emphasis on their phenotypic evolution. With the recent discovery that HCS is caused by mutations in NOTCH2, DNA from the both cases was examined and both were found to have truncating mutations in exon 34 of NOTCH2. The phenotypic evolution of SFPKS and this molecular analysis strongly suggest that SFPKS is part of the phenotypic spectrum of HCS and should no longer be classified as a distinct disease entity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21712856      PMCID: PMC3234501          DOI: 10.1038/ejhg.2011.125

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  15 in total

1.  Serpentine fibula syndrome: a variant clinical presentation of Hajdu-Cheney syndrome?

Authors:  J P Fryns
Journal:  Clin Dysmorphol       Date:  1997-07       Impact factor: 0.816

Review 2.  Serpentine fibula syndrome: expansion of the phenotype with three affected siblings.

Authors:  E M Rosser; N P Mann; C M Hall; R M Winter
Journal:  Clin Dysmorphol       Date:  1996-04       Impact factor: 0.816

3.  Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis.

Authors:  Bertrand Isidor; Pierre Lindenbaum; Olivier Pichon; Stéphane Bézieau; Christian Dina; Sébastien Jacquemont; Dominique Martin-Coignard; Christel Thauvin-Robinet; Martine Le Merrer; Jean-Louis Mandel; Albert David; Laurence Faivre; Valérie Cormier-Daire; Richard Redon; Cédric Le Caignec
Journal:  Nat Genet       Date:  2011-03-06       Impact factor: 38.330

4.  Further evidence that the Hajdu-Cheney syndrome and the "serpentine fibula-polycystic kidney syndrome" are a single entity.

Authors:  F J Ramos; B S Kaplan; R D Bellah; E H Zackai; P Kaplan
Journal:  Am J Med Genet       Date:  1998-08-06

5.  Melnick-Needles syndrome (osteodysplasty). Clinical and radiological heterogeneity.

Authors:  A M Dereymaeker; J Christens; R Eeckels; G Heremans; J P Fryns
Journal:  Helv Paediatr Acta       Date:  1986-10

6.  Serpentine fibula--polycystic kidney syndrome and Melnick-Needles syndrome are different disorders.

Authors:  F Majewski; H Enders; M B Ranke; T Voit
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

7.  Serpentine fibula--polycystic kidney syndrome. A variant of the Melnick-Needles syndrome or a distinct entity?

Authors:  G U Exner
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

Review 8.  Cystic kidney disease in Hajdu-Cheney syndrome.

Authors:  P Kaplan; F Ramos; E H Zackai; R D Bellah; B S Kaplan
Journal:  Am J Med Genet       Date:  1995-03-13

9.  Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality.

Authors:  Y Hamada; Y Kadokawa; M Okabe; M Ikawa; J R Coleman; Y Tsujimoto
Journal:  Development       Date:  1999-08       Impact factor: 6.868

Review 10.  Nosology and classification of genetic skeletal disorders: 2010 revision.

Authors:  Matthew L Warman; Valerie Cormier-Daire; Christine Hall; Deborah Krakow; Ralph Lachman; Martine LeMerrer; Geert Mortier; Stefan Mundlos; Gen Nishimura; David L Rimoin; Stephen Robertson; Ravi Savarirayan; David Sillence; Juergen Spranger; Sheila Unger; Bernhard Zabel; Andrea Superti-Furga
Journal:  Am J Med Genet A       Date:  2011-03-15       Impact factor: 2.802

View more
  29 in total

Review 1.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

Review 2.  Notch signaling in human development and disease.

Authors:  Andrea L Penton; Laura D Leonard; Nancy B Spinner
Journal:  Semin Cell Dev Biol       Date:  2012-01-28       Impact factor: 7.727

Review 3.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

Review 4.  Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.

Authors:  Ernesto Canalis; Stefano Zanotti
Journal:  Curr Osteoporos Rep       Date:  2016-08       Impact factor: 5.096

5.  Mice harboring a Hajdu Cheney Syndrome mutation are sensitized to osteoarthritis.

Authors:  S Zanotti; J Yu; D Bridgewater; J M Wolf; E Canalis
Journal:  Bone       Date:  2018-06-22       Impact factor: 4.398

Review 6.  Notch Signaling and the Skeleton.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2016-04-13       Impact factor: 19.871

Review 7.  Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.

Authors:  Ernesto Canalis
Journal:  Metabolism       Date:  2017-08-24       Impact factor: 8.694

8.  Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome.

Authors:  W Zhao; E Petit; R I Gafni; M T Collins; P G Robey; M Seton; K K Miller; M Mannstadt
Journal:  Osteoporos Int       Date:  2013-02-07       Impact factor: 4.507

9.  Induction of the Hajdu-Cheney Syndrome Mutation in CD19 B Cells in Mice Alters B-Cell Allocation but Not Skeletal Homeostasis.

Authors:  Jungeun Yu; Stefano Zanotti; Lauren Schilling; Chris Schoenherr; Aris N Economides; Archana Sanjay; Ernesto Canalis
Journal:  Am J Pathol       Date:  2018-03-12       Impact factor: 4.307

10.  The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  J Biol Chem       Date:  2019-08-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.